SOP Sample Clauses
The SOP (Standard Operating Procedure) clause defines the required procedures and protocols that parties must follow when performing specific tasks or processes under the agreement. It typically outlines step-by-step instructions, documentation requirements, and compliance standards to ensure consistency and quality in operations. By establishing clear and uniform methods, the SOP clause helps prevent misunderstandings, reduces errors, and ensures that all parties adhere to agreed-upon practices, thereby promoting efficiency and accountability.
POPULAR SAMPLE Copied 2 times
SOP. Institutions engaged in human research can rely on other IRBs for review and approval of human research. An agreement must be negotiated and documented between the institution conducting the human research and the IRB reviewing the research before the research can begin locally. Those research studies that ECU determines cannot rely on another IRB will be submitted for UMCIRB approval as usual with documentation for that decision.
SOP. This model is designed to be implemented alongside the current tiered model of ▇▇▇▇▇▇ care. The State has defined a STAT home as a family alternative to residential placement for children requiring a behavioral health intervention. DHHR reported that the adoption of the name STAT Home was the result of input from Child Placing Agencies (CPAs), which occurred over the course of bi-weekly meetings held from January 7-March 4, 2022. The name is meant to convey that the STAT home is a short-term, stabilizing intervention, with a goal of the child returning home or to another family setting. Children and youth served in the three tiers of ▇▇▇▇▇▇ care will be evaluated for STAT home eligibility if there is a “disruption.” This model makes slight updates to the definition of eligible STAT home participants. Children and youth are eligible if they meet all of the following criteria: • Age 4 through 20; • In state custody; • Approved CSED Waiver participant; • Cannot be safely served in their own (or kinship) home and require a STAT Home setting to receive behavioral health interventions; and • Not an immediate danger to others or self, or a habitual flight risk which cannot be safely addressed through a safety plan/flight risk plan. The most updated SOP provides a scenario for how children may enter a STAT home after receiving services in a RMHTF. BSS has developed a proposed rate of $220 per day for its STAT homes. Of that, $135 would be allocated to the provider to reimburse them for oversight and supervisory activities, training, data collection, and general services to support and retain the ▇▇▇▇▇▇ family. The remaining $85/day would go directly to the STAT Home Family to cover treatment support (participation in meetings, training, and other treatment-oriented appointments) and room and board. This is an increase of $54 per day above the current highest rate paid to traditional ▇▇▇▇▇▇ families (serving youth 13-21). The BSS rate is a flat rate regardless of the age of the child (versus the tiered rate structure for families in traditional ▇▇▇▇▇▇ care). BSS has outlined training requirements for STAT homes, including content on working with children with exceptional needs, PBS, working with primary families, and more. The CPAs are expected to provide or facilitate access to trainings on medication administration; Trauma Systems Therapy; LGBTQ+ children and youth; sexual development and pregnancy prevention; and advanced crisis prevention, intervention, and de-...
SOP. This clause has been drawn to my attention and I confirm that I understand and accept its legal consequences. Parent 1 Parent 2 Person /Company responsible for Account
SOP o Be punctual and efficient in dealing with requests • The service provider must provide a list of all buses used including the driver’s details (master list) in the first stage from submitting the tender. مسقلا يف ةجردملا ةلصلا تاذ تادنتسملاو نيينعملا نيقئاسلا ءامسأ عيمج كلذ يف امب دقاعتلا ةلاح يف اهمادختسا مزتعي يتلا تلافاحلا عيمجب ةمئاق همدق يذلا ءاطعلا عم ةمدخلا دوزم مدقي نأ بجي • .سداسلا • In case the service provider intends to change or add ▇▇▇▇ or drivers, the service provider must inform the contracting agency at least 3 working days in advance and provide the necessary documentation as listed above. • All costs associated with this activity are the sole responsibility of the service provider. Busses must indicate regular maintenance. The contracting agency will conduct unannounced spot-checks to check the ▇▇▇▇ condition. In case service provider wishes to change a ▇▇▇▇, capacity and condition checks will be conducted by the contracting agency prior adding the ▇▇▇▇ to the master list. • The contracting agency may share the master list with the service provider. The service provider is responsible to ensure that the information is correct. • The service provider is responsible to clean and disinfect the ▇▇▇▇ on daily basses. • All busses must be adequately maintained. The contracting agency reserves the right to conduct unannounced spot checks on the condition of the ▇▇▇▇. If a ▇▇▇▇ is found in an unsatisfactory condition, the contracting agency may remove the ▇▇▇▇ from the master list until repairs have been carried out by the service provider. The ▇▇▇▇ condition must not endanger people, roads, buildings... Maintenance requested by the contracting agency shall be addressed by the service provider within five working days. The contracting agency will conduct visit in order to evaluate the condition of the bus during the tendering phase.
SOP. For Standard Operating Procedure. It is a tool as part of a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final Product. The main risks are:
a) Unexpected contamination of Products, causing damage to health or even death.
b) Incorrect labels on containers, which could mean that patients receive the wrong medicine.
c) Insufficient or too much active ingredient, resulting in ineffective treatment or adverse effects.
SOP. 14.3.1 Consistent with the above, ▇▇▇▇▇▇ and Acambis shall jointly develop certain procedures with regard to Pharmacovigilance & Field Corrective Actions (including Recall) within three months of the execution date of this Agreement. Back to Contents
SOP. 003‐2 The minimum level of service is defined as below; Power is avail ble All computers are in working order Environment of the Telecenter is conducive and clean. Working hours should be strictly observed Cooperative and Friendly attitude of Telecenter employees towards general public. SOP Category Miscella eous(004) SOP Name Theft Reporting SOP No. SOP‐004‐1 There should be a proper mechanism for theft reporting in case of theft at Telecenter SOP Category Miscella eous(004) SOP Name Telecenter User Facilitation SOP No. SOP‐004‐2 a M m n n n n r It is the primary responsibility of the Supervisor to facilitate the users, however all Telecenter employee should show empathy towards the users and should facilitate users. Special Consideration should be given to disabled people and maximum facilitation should be provided to them. SOP Category Miscella eous(004) SOP Name Dispute esolution SOP No. SOP‐004‐3 A proper mechanism for the resolution of disputes related to Telecenter’s operation SOP Category Miscella eous(004) SOP Name Disciplinary Action SOP No. SOP‐004‐4 USF holds authority to take disciplinary action against the employees of Telecenter in case of violation of the Code of Conduct, Malpractice or any other wrong doing. However the Service Provider will have a mechanism for disciplinary actions. Disciplinary action may include the following: 1. Verbal Warning – After 3 verbal warnings a written warning shall be issued. 2. Written Warning – After 3 written warnings any employee can be terminated. Written warnings can be given without any prior verbal warning. 3. Termination – USF has the right to terminate any employee depending on the allegation SOP Category Miscella eous(004) SOP Name Facility Improvement Suggestions SOP No. SOP‐004‐5 Every Telecen er will have a suggestion and improvement box placed at a visible place, and all suggestions will be mailed to USF every month. Contact details of designated officials of the Service Providers and USF should be displayed at a conspicuous place. In addition to the suggestion box, suggestions can be directly routed to USF through Email, Land Mail, and Fax on the designated addresses. SOP Category Miscella eous(004) SOP Name Code of Conduct for sers of Telecenters n R n a n n C U
SOP. 120622-SOL1-01 Other: MVR-140214-KA2-01 (Yearly evaluation of validation status of analytical methods for CYT003-QbG10, Oligonucleotide G10 and Qbeta transferred to Solvias AG) SCHEDULE 1.63
4.4 Documents to be transferred for product-specific in-house standards used for analytics of Qbeta Dimer and CYT003-QbG10 Oligonucleotide G10 ± x nucleotides IS027 SPC-IS027-02 COA-131014-KA2-01 CYT003-QbG10 IS040 SPEC-IS040-03 ▇▇▇-▇▇▇▇▇▇-▇▇▇-▇▇ ▇▇▇▇▇ IS048 SPEC-IS048-02 ▇▇▇-▇▇▇▇▇▇-▇▇▇-▇▇ ▇▇▇▇▇ Dimer IS055 SPEC-IS055-01 COA-140113-KA2-01 SCHEDULE 1.63 5 PRECLINICAL REPORTS TO BE TRANSFERED TO CHECKMATE
5.1 Preclinical reports on CYT003
5.1.1 Non-GLP reports PK report No 1 Half-life of Qb in mouse PK Pk report No 1 Pharmacokinetics of QbG10 in mouse PK CYT003-QbG10: PK report No 2 Serum half-life of QbG10 in ▇▇▇▇▇▇▇-▇▇▇▇▇▇ rats injected intravenously with QbG10 PK CYT003-QbG10: PK report No 3 Pharmacokinetics of QbG10 in ▇▇▇▇▇▇▇-▇▇▇▇▇▇ rats after subcutaneous injection PK CYT003-QbG10: PK report No 4, Stability of QbG10 in human serum in vitro PK PPD report No 2 Stimulation of human T and B cells by G10 PD PPD report No 3 TLR9-dependent signaling of G10 PD PPD report No 4 Stimulation of mouse dendritic cells by QbG10 in vivo and in vitro PD PPD report No 5 Induction of T cell expansion and IFNy production by QbG10 in mice PD PPD report No 6 Efficacy of QbG10 in a ragweed-based allergy and asthma model in mice PD CYT003-QbG10: PPD report No 7 Uptake of QbGl0 by human pDCs in the presence of Qb-pecific antibodies PD CYT003-QbG10: PPD report No 8 Stimulation of human PBMCs in the presence of Qb-pecific antibodies PD SCHEDULE 1.63 CYT003-QbG10: PPD report No 9 Upregulation of ICOS-L on human pDCs treated with QbGl0 in the presence and absence of Qb-specific antibodies PD CYT003-QbG10: PPD report No 10 Analysis of IgG subclasses in ▇▇▇▇▇▇▇-▇▇▇▇▇▇ rats immunized with QbGl0 or QbpGlu PD Report of Antibody Determination from: Effects of QbGl0 Following Repeat-Dose Subcutaneous Administration to the ▇▇▇▇▇ Rat (Covance Study 2970/001) PD
5.1.2 GLP-reports (Toxicology Studies) Acute Intravenous Toxicity Test in Rats following a Single Administration of QBG10 Single dose acute toxicity 506169 Repeat Dose and Local Tolerance Toxicity Study in Rats Following Multiple Subcutaneous Administrations of QBG10 Repeat dose, local tolerance 505893 Local Tolerance and Toxicity Study of QbG10 in Rats with 7 Subcutaneous Injections Repeat dose, local tolerance 512497 Effects of QbG10 Following...
SOP. At any time during or after the course of the Project, WeRide shall and shall ensure its Affiliates to follow ▇▇▇▇▇’s instruction (if any) to transfer the Bosch Foreground Data to the Legal Person designated by Bosch who is qualified under applicable laws and regulations to own and control such Data.
SOP. Rosetta shall perform each Diagnostic Test according to the standard operating procedures (“SOP”) agreed upon in writing by the Parties, which may be amended from time to time subject to the Parties’ mutual written consent. Rosetta agrees not to change or deviate from the SOP without Prometheus’ prior written approval.
